Liquid chromatographic determination of ketoconazole, a potent inhibitor of CYP3A4-mediated metabolism
- 9 March 2001
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 753 (2) , 395-400
- https://doi.org/10.1016/s0378-4347(00)00573-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Analysis of some antifungal drugs by spectrophotometric and spectrofluorimetric methods in different pharmaceutical dosage formsJournal of Pharmaceutical and Biomedical Analysis, 2000
- Effects of the Antifungal Agents on Oxidative Drug MetabolismClinical Pharmacokinetics, 2000
- Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 InhibitionClinical Pharmacokinetics, 2000
- Predicting Drug Interactions In Vivo from Experiments In VitroAmerican Journal of Clinical Oncology, 1997
- Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary cultureThe FASEB Journal, 1992
- Clinical Pharmacokinetics of KetoconazoleClinical Pharmacokinetics, 1988
- High performance liquid chromatographic determination of ketoconazole in human serumJournal of Antimicrobial Chemotherapy, 1986
- Sensitive bioassay for ketoconazole in serum and cerebrospinal fluidAntimicrobial Agents and Chemotherapy, 1981
- Liquid chromatographic assay of ketoconazoleAntimicrobial Agents and Chemotherapy, 1981
- Determination of the antifungal agent, ketoconazole, in human plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1980